Literature DB >> 10974333

Opposite modulation of histaminergic neurons by nociceptin and morphine.

K S Eriksson1, D R Stevens, H L Haas.   

Abstract

We have studied the effects of nociceptin/orphanin FQ on the histaminergic neurons in the tuberomammillary (TM) nucleus and compared them with the actions of opioid agonists. Intracellular recordings of the membrane potential were made with sharp electrodes from superfused rat hypothalamic slices. Nociceptin strongly inhibited the firing of the TM neurons. In the concentration range 10-300 nM, nociceptin hyperpolarized the neurons in a dose-dependent and reversible manner. Insensitivity to tetrodotoxin indicated a postsynaptic effect which was associated with decreased input resistance. Voltage-current plots suggested the involvement of a potassium conductance which was highly sensitive to Ba(2+) and decreased by Cs(+), in keeping with the activation of an inwardly rectifying potassium channel. Morphine (20-100 microM) depolarized the TM neurons and increased their firing, and this effect was blocked by tetrodotoxin. Dynorphin A(1-13) at 100-300 nM did not affect the TM neurons. Nociceptin and morphine modulate the activity of the TM neurons, and most likely histamine release, in opposite ways. Histamine has an antinociceptive effect in the brain and may be involved in opioid-induced analgesia. Nociceptin might therefore influence pain transmission by inhibiting opioid-induced histamine release from the TM nucleus and also modulate other physiological mechanisms which have been ascribed to the histaminergic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974333     DOI: 10.1016/s0028-3908(00)00062-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  Electrophysiological Properties of Genetically Identified Histaminergic Neurons.

Authors:  Natalie J Michael; Jeffrey M Zigman; Kevin W Williams; Joel K Elmquist
Journal:  Neuroscience       Date:  2020-06-27       Impact factor: 3.590

2.  Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain.

Authors:  Gabriele Cenni; Patrizio Blandina; Ken Mackie; Daniele Nosi; Lucia Formigli; Patrizia Giannoni; Chiara Ballini; Laura Della Corte; Pier Francesco Mannaioni; M Beatrice Passani
Journal:  Eur J Neurosci       Date:  2006-09       Impact factor: 3.386

3.  Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura.

Authors:  Umberto Pietrini; Massimo De Luca; Enrico Del Bene; Francesco De Cesaris; Luca Bertinotti; Nicola Colangelo; Alberto Moggi Pignone
Journal:  Curr Ther Res Clin Exp       Date:  2004-01

4.  Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus.

Authors:  Mary-Ann Greco; Patrick M Fuller; Thomas C Jhou; S Martin-Schild; James E Zadina; Zhian Hu; Priyattam Shiromani; Jun Lu
Journal:  Brain Res       Date:  2008-09-24       Impact factor: 3.252

5.  Morphine inhibits sleep-promoting neurons in the ventrolateral preoptic area via mu receptors and induces wakefulness in rats.

Authors:  Qin Wang; Xiao-Fang Yue; Wei-Min Qu; Rong Tan; Ping Zheng; Yoshihiro Urade; Zhi-Li Huang
Journal:  Neuropsychopharmacology       Date:  2012-11-30       Impact factor: 7.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.